Swedish Orphan Biovitrum AB (publ) (Sobi) today announced its results for the fourth quarter and full year 2013. Revenues for the year totalled SEK 2,177 M (1,923), an increase of 13 per cent. Revenues in the fourth quarter were 29 per cent higher compared to the previous year. All parts of the business contributed to the result with Kineret® and Partner Products delivering strong performance.
Help employers find you! Check out all the jobs and post your resume.
